[S02DA03, antipyrine, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Antipyrine.]
[B01AD01, streptokinase, The therapeutic efficacy of Streptokinase can be decreased when used in combination with Cefotetan.]
[J01GA01, streptomycin, Cefotetan may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Cefotetan may decrease the excretion rate of Sucralfate which could result in a higher serum level.]
[J01CG01, sulbactam, Cefotetan may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Cefotetan may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Cefotetan may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.]
[M01AB02, sulindac, The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Cefotetan.]
[M01AX04, apazone, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Azapropazone.]
[N05CD07, temazepam, Cefotetan may decrease the excretion rate of Temazepam which could result in a higher serum level.]
[R03CC03, terbutaline, Cefotetan may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Cefotetan may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Cefotetan may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Tetracaine.]
[S03AA02, tetracycline, Cefotetan may decrease the excretion rate of Tetracycline which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Ceftaroline fosamil.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Cefotetan may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Cefotetan may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.]
[G04BE06, moxisylyte, Cefotetan may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Cefotetan may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Cefotetan may decrease the excretion rate of Ticlopidine which could result in a higher serum level.]
[S01ED01, timolol, Cefotetan may decrease the excretion rate of Timolol which could result in a higher serum level.]
[P01AB02, tinidazole, Cefotetan may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Cefotetan may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Cefotetan may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, Cefotetan may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Cefotetan.]
[N02AX02, tramadol, Cefotetan may decrease the excretion rate of Tramadol which could result in a higher serum level.]
[C03DB02, triamterene, The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cefotetan.]
[N05CD05, triazolam, Cefotetan may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Cefotetan may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Cefotetan may decrease the excretion rate of Trifluridine which could result in a higher serum level.]
[A03AA05, trimebutine, Cefotetan may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[J01EA01, trimethoprim, Cefotetan may decrease the excretion rate of Trimethoprim which could result in a higher serum level.]
[R03DX07, roflumilast, Cefotetan may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Cefotetan may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Cefotetan may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[B01AD04, urokinase, The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefotetan.]
[S01AA28, vancomycin, Cefotetan may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Cefotetan may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Cefotetan may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC24, ticagrelor, The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Cefotetan.]
[C08DA01, verapamil, Cefotetan may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N06AX09, viloxazine, Cefotetan may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[B03BA01, vitamin B12, Cefotetan may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.]
[B01AA03, warfarin, Cefotetan may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA03, pamidronic acid, The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Cefotetan.]
[M05BA05, tiludronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotetan is combined with Tiludronic acid.]
[B06AC02, icatibant, Cefotetan may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[B01AE01, desirudin, The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotetan.]
[A02BC04, rabeprazole, Cefotetan may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotetan is combined with Ibandronate.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Cefotetan may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Cefotetan.]
[L01EJ01, ruxolitinib, Cefotetan may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Cefotetan may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, Cefotetan may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[M01CB03, auranofin, Cefotetan may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[B03XA04, peginesatide, Cefotetan may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Cefotetan may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Cefotetan may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Cefotetan may decrease the excretion rate of Gemcitabine which could result in a higher serum level.]
[J01DF01, aztreonam, Cefotetan may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[R02AB04, bacitracin, The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Cefotetan.]
[M03BX01, baclofen, Cefotetan may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A08AA11, lorcaserin, Cefotetan may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Cefotetan may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[L02BB04, enzalutamide, Cefotetan may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[B01AX01, defibrotide, The therapeutic efficacy of Defibrotide can be decreased when used in combination with Cefotetan.]
[D02BA02, octinoxate, Cefotetan may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[N04BD02, rasagiline, Cefotetan may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[V09IX04, fluorodeoxyglucose F18, Cefotetan may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[V08CA11, gadofosveset, Cefotetan may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[B01AF02, apixaban, The therapeutic efficacy of Apixaban can be decreased when used in combination with Cefotetan.]
[A16AX08, teduglutide, Cefotetan may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Cefotetan may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Cefotetan may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Cefotetan may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Benorilate.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Benzocaine.]
[L03AA12, ancestim, Cefotetan may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Cefotetan.]
[N04AC01, benztropine, Cefotetan may decrease the excretion rate of Benzatropine which could result in a higher serum level.]
[R02AX03, benzydamine, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Benzydamine.]
[L01EE01, trametinib, Cefotetan may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Cefotetan may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Cefotetan may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[A10BJ03, lixisenatide, Cefotetan may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Cefotetan may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Cefotetan may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Cefotetan may decrease the excretion rate of Etonogestrel which could result in a higher serum level.]
[J05AP08, sofosbuvir, Cefotetan may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Cefotetan may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, Cefotetan may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Cefotetan may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Cefotetan may decrease the excretion rate of Formestane which could result in a higher serum level.]
[B01AE03, argatroban, The therapeutic efficacy of Argatroban can be decreased when used in combination with Cefotetan.]
[V03AB34, fomepizole, Cefotetan may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[B01AC26, vorapaxar, The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Cefotetan.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Cefotetan is combined with Acenocoumarol.]
[V08AA01, diatrizoic acid, Cefotetan may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[V08AA04, iothalamic acid, Cefotetan may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Dihydrostreptomycin.]
[S03AA06, gentamicin, Cefotetan may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Cefotetan is combined with Dicoumarol.]
[B01AF03, edoxaban, Cefotetan may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N02BE01, acetaminophen, Cefotetan may decrease the excretion rate of Acetaminophen which could result in a higher serum level.]
[L01DC01, bleomycin, Cefotetan may decrease the excretion rate of Bleomycin which could result in a higher serum level.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Cefotetan is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Cefotetan.]
[B01AC25, cangrelor, The therapeutic efficacy of Cangrelor can be decreased when used in combination with Cefotetan.]
[M02AA25, aceclofenac, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Acemetacin.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB37, idarucizumab, Cefotetan may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Cefotetan.]
[L01XG03, ixazomib, Cefotetan may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[M04AB05, lesinurad, Cefotetan may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Alminoprofen.]
[N03AX23, brivaracetam, Cefotetan may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[N05BA08, bromazepam, Cefotetan may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Cefotetan may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C03CA02, bumetanide, The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Cefotetan.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Bupivacaine.]
[N05BE01, buspirone, Cefotetan may decrease the excretion rate of Buspirone which could result in a higher serum level.]
[L01XX27, arsenic trioxide, Cefotetan may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[M02AA03, clofezone, Cefotetan may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[A07EC04, balsalazide, The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Cefotetan.]
[A06AH05, naldemedine, Cefotetan may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Cefotetan may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Cefotetan may decrease the excretion rate of Pregabalin which could result in a higher serum level.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Oxybuprocaine.]
[P01CA02, benznidazole, Cefotetan may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Cefotetan may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[N07XX13, valbenazine, Cefotetan may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[J01MA23, delafloxacin, Cefotetan may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[B01AF04, betrixaban, The therapeutic efficacy of Betrixaban can be decreased when used in combination with Cefotetan.]
[L01BC06, capecitabine, Cefotetan may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[C07AB07, bisoprolol, Cefotetan may decrease the excretion rate of Bisoprolol which could result in a higher serum level.]
[J01DC10, cefprozil, The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Cefotetan.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Cefotetan may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Bumadizone.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Cefotetan may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[L02BB05, apalutamide, Cefotetan may decrease the excretion rate of Apalutamide which could result in a higher serum level.]
[N03AF01, carbamazepine, Cefotetan may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AA37, baricitinib, Cefotetan may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Cefepime.]
[J01DD10, cefetamet, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Cefetamet.]
[J01DD09, cefodizime, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Cefodizime.]
[J01DC11, ceforanide, The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Cefotetan.]
[J01DD13, cefpodoxime, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Cefpodoxime.]
[J01DD14, ceftibuten, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Ceftibuten.]
[J01GB14, plazomicin, Cefotetan may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[A16AX14, migalastat, Cefotetan may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, Cefotetan may decrease the excretion rate of Stiripentol which could result in a higher serum level.]
[S01GX12, cetirizine, Cefotetan may decrease the excretion rate of Cetirizine which could result in a higher serum level.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Cefotetan may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Lornoxicam.]
[N07XX15, inotersen, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Inotersen.]
[L01AD01, carmustine, Cefotetan may decrease the excretion rate of Carmustine which could result in a higher serum level.]
[A06AX05, prucalopride, Cefotetan may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC23, cilostazol, Cefotetan may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[N06BA14, solriamfetol, Cefotetan may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, Cefotetan may decrease the excretion rate of Clobazam which could result in a higher serum level.]
[J01DC04, cefaclor, The risk or severity of nephrotoxicity can be increased when Cefaclor is combined with Cefotetan.]
[J01DB05, cefadroxil, The risk or severity of nephrotoxicity can be increased when Cefadroxil is combined with Cefotetan.]
[J01DC03, cefamandole, The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Cefotetan.]
[J01DB07, cefatrizine, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Cefatrizine.]
[J01DB04, cefazolin, The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Cefotetan.]
[J01DC09, cefmetazole, The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Cefotetan.]
[J01DC06, cefonicid, The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Cefotetan.]
[J01DD12, cefoperazone, The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Cefotetan.]
[J01DD01, cefotaxime, The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Cefotetan.]
[J01DC07, cefotiam, The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Cefotetan.]
[J01DC01, cefoxitin, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Cefoxitin.]
[J01DD03, cefsulodin, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Cefsulodin.]
[J01DD02, ceftazidime, The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Cefotetan.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Ceftizoxime.]
[J01DD04, ceftriaxone, The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Cefotetan.]
[S01AA27, cefuroxime, The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Cefotetan.]
[N07XX11, pitolisant, Cefotetan may decrease the excretion rate of Pitolisant which could result in a higher serum level.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Cefotetan may decrease the excretion rate of Daptomycin which could result in a higher serum level.]
[J01DB01, cephalexin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefotetan.]
[J01DB02, cephaloridine, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Cefaloridine.]
[J01DB03, cephalothin, The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Cefotetan.]
[J01DB08, cephapirin, The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Cefotetan.]
[J01DB09, cephradine, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Cefradine.]
[A16AX16, givosiran, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Givosiran.]
[M09AX08, golodirsen, Cefotetan may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Cefotetan may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[R02AA03, dichlorobenzyl alcohol, Cefotetan may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Cefotetan may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, The risk or severity of nephrotoxicity can be increased when Rofecoxib is combined with Cefotetan.]
[C08CA16, clevidipine, Cefotetan may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[M01AC04, droxicam, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Droxicam.]
[V08CA05, mangafodipir, Cefotetan may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[B01AE02, lepirudin, The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefotetan.]
[M02AA27, dexketoprofen, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Dexketoprofen.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Dyclonine.]
[P01BA01, chloroquine, Cefotetan may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Cefotetan may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.]
[A10BB02, chlorpropamide, Cefotetan may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Cefotetan may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.]
[N02BA07, ethenzamide, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Ethenzamide.]
[M01AB08, etodolac, The risk or severity of nephrotoxicity can be increased when Etodolac is combined with Cefotetan.]
[M02AA06, etofenamate, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Etofenamate.]
[M01AX25, chondroitin sulfates, Cefotetan may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[M01AE05, fenbufen, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Fenbufen.]
[C01CA19, fenoldopam, Cefotetan may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[J01DD15, cefdinir, Cefotetan may decrease the excretion rate of Cefdinir which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Cefotetan may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.]
[N02BG07, flupirtine, Cefotetan may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[A02BA01, cimetidine, Cefotetan may decrease the excretion rate of Cimetidine which could result in a higher serum level.]
[V08CA04, gadoteridol, Cefotetan may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[S03AA07, ciprofloxacin, Cefotetan may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.]
[L01XA01, cisplatin, Cefotetan may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AG01, mefenamic acid, The risk or severity of nephrotoxicity can be increased when Mefenamic acid is combined with Cefotetan.]
[B01AD11, tenecteplase, The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefotetan.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Levobupivacaine.]
[N06AA04, clomipramine, Cefotetan may decrease the excretion rate of Clomipramine which could result in a higher serum level.]
[N03AE01, clonazepam, Cefotetan may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[J05AH02, oseltamivir, Cefotetan may decrease the excretion rate of Oseltamivir which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Cefotetan may decrease the excretion rate of Clozapine which could result in a higher serum level.]
[J01GB12, arbekacin, Cefotetan may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Cocaine.]
[M01AX13, proquazone, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Proquazone.]
[M04AC01, colchicine, Cefotetan may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Cefotetan may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Cefpirome.]
[A04AA03, tropisetron, Cefotetan may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Cefotetan may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Imidazole salicylate.]
[B01AC10, indobufen, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Indobufen.]
[J05AB14, valganciclovir, Cefotetan may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Cefotetan may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Cefotetan may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Cefotetan may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Cefotetan may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Cefotetan may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Cefotetan.]
[N02CC05, almotriptan, Cefotetan may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Parecoxib.]
[B01AB12, bemiparin, The therapeutic efficacy of Bemiparin can be decreased when used in combination with Cefotetan.]
[S01AD03, acyclovir, The risk or severity of nephrotoxicity can be increased when Acyclovir is combined with Cefotetan.]
[N05BA10, ketazolam, Cefotetan may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Kebuzone.]
[N03AX09, lamotrigine, Cefotetan may decrease the excretion rate of Lamotrigine which could result in a higher serum level.]
[N07BC04, lofexidine, Cefotetan may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Lonazolac.]
[M02AA31, loxoprofen, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Loxoprofen.]
[J01DC08, loracarbef, The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Cefotetan.]
[C09AA03, lisinopril, Cefotetan may decrease the excretion rate of Lisinopril which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Cefotetan may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[J01DH02, meropenem, Cefotetan may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Cefotetan may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Cefotetan may increase the nephrotoxic activities of Tenofovir disoproxil.]
[S01XA18, cyclosporine, The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefotetan.]
[M02AA02, mofebutazone, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Morniflumate.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AH05, etoricoxib, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Etoricoxib.]
[L01AX04, dacarbazine, Cefotetan may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[M01AX01, nabumetone, The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cefotetan.]
[N07BB05, nalmefene, Cefotetan may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[S01GX04, nedocromil, Cefotetan may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Cefotetan may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, Cefotetan may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Cefotetan may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[M03AC11, cisatracurium, Cefotetan may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, Cefotetan may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[A07EC03, olsalazine, The risk or severity of nephrotoxicity can be increased when Olsalazine is combined with Cefotetan.]
[N06AA01, desipramine, Cefotetan may decrease the excretion rate of Desipramine which could result in a higher serum level.]
[H01BA02, desmopressin, Cefotetan may decrease the excretion rate of Desmopressin which could result in a higher serum level.]
[V04CH02, indigo carmine, Cefotetan may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Cefotetan may decrease the excretion rate of Ertapenem which could result in a higher serum level.]
[M01AE12, oxaprozin, The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Cefotetan.]
[N06BA02, dextroamphetamine, Cefotetan may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Cefotetan may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[P03AC04, permethrin, Cefotetan may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Cefotetan may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Cinchocaine.]
[R05DA08, pholcodine, Cefotetan may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[M05BA02, clodronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotetan is combined with Clodronic acid.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The risk or severity of nephrotoxicity can be increased when Diclofenac is combined with Cefotetan.]
[J05AD01, foscarnet, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Foscarnet.]
[A03AA07, dicyclomine, Cefotetan may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Cefotetan may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA03, isradipine, Cefotetan may decrease the excretion rate of Isradipine which could result in a higher serum level.]
[D07XC04, diflucortolone, Cefotetan may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, The risk or severity of nephrotoxicity can be increased when Diflunisal is combined with Cefotetan.]
[C01AA05, digoxin, Cefotetan may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02AA03, hydromorphone, Cefotetan may decrease the excretion rate of Hydromorphone which could result in a higher serum level.]
[L04AX04, lenalidomide, Cefotetan may decrease the excretion rate of Lenalidomide which could result in a higher serum level.]
[J05AE08, atazanavir, The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Cefotetan.]
[H03BC01, potassium perchlorate, Cefotetan may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Cefotetan may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Pramocaine.]
[V03AB09, dimercaprol, Cefotetan may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Cefotetan may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N02BB04, propyphenazone, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Proglumetacin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Diphenhydramine.]
[B01AC07, dipyridamole, The therapeutic efficacy of Dipyridamole can be decreased when used in combination with Cefotetan.]
[B01AD10, drotrecogin alfa, The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Cefotetan.]
[S01AX06, resorcinol, Cefotetan may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Cefotetan may decrease the excretion rate of Disopyramide which could result in a higher serum level.]
[P03AA04, disulfiram, The risk or severity of adverse effects can be increased when Cefotetan is combined with Disulfiram.]
[R06AE09, levocetirizine, Cefotetan may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Ropivacaine.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, Cefotetan may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cefotetan.]
[C01EB18, ranolazine, Cefotetan may decrease the excretion rate of Ranolazine which could result in a higher serum level.]
[N02BA06, salsalate, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Salsalate.]
[H05BA01, salmon calcitonin, Cefotetan may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.]
[C01CA07, dobutamine, Cefotetan may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, Cefotetan may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA12, doxepin, Cefotetan may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[J01AA02, doxycycline, Cefotetan may decrease the excretion rate of Doxycycline which could result in a higher serum level.]
[A08AA10, sibutramine, Cefotetan may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[A12CA02, sodium sulfate, Cefotetan may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Cefotetan may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, Cefotetan may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, Cefotetan may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[L01AX03, temozolomide, Cefotetan may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Cefotetan.]
[M01AG02, tolfenamic acid, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Tolfenamic acid.]
[N06AG03, toloxatone, Cefotetan may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Cefotetan may decrease the excretion rate of Atomoxetine which could result in a higher serum level.]
[N03AX11, topiramate, Cefotetan may decrease the excretion rate of Topiramate which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Cefotetan may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[B01AC18, triflusal, The therapeutic efficacy of Triflusal can be decreased when used in combination with Cefotetan.]
[C05CA04, troxerutin, The therapeutic efficacy of Troxerutin can be decreased when used in combination with Cefotetan.]
[N06AX16, venlafaxine, Cefotetan may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[M01AB04, zomepirac, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Zomepirac.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AD03, anistreplase, The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefotetan.]
[L01XA02, carboplatin, The risk or severity of nephrotoxicity can be increased when Carboplatin is combined with Cefotetan.]
[C02AC02, guanfacine, Cefotetan may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[L03AX05, pidotimod, Cefotetan may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, Cefotetan may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, Cefotetan may decrease the excretion rate of Pantoprazole which could result in a higher serum level.]
[G03CA03, estradiol, Cefotetan may decrease the excretion rate of Estradiol which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Cefotetan may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.]
[J04AK02, ethambutol, Cefotetan may decrease the excretion rate of Ethambutol which could result in a higher serum level.]
[V08CA03, gadodiamide, Cefotetan may decrease the excretion rate of Gadodiamide which could result in a higher serum level.]
[C01BD05, ibutilide, Cefotetan may decrease the excretion rate of Ibutilide which could result in a higher serum level.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Etidocaine.]
[N01AX07, etomidate, Cefotetan may decrease the excretion rate of Etomidate which could result in a higher serum level.]
[L04AD02, tacrolimus, The risk or severity of nephrotoxicity can be increased when Tacrolimus is combined with Cefotetan.]
[P01AX07, trimetrexate, Cefotetan may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Cefotetan may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, Cefotetan may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.]
[L02AE02, leuprolide, Cefotetan may decrease the excretion rate of Leuprolide which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Cefotetan may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Cefotetan may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Cefotetan may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.]
[A16AA01, levocarnitine, Cefotetan may decrease the excretion rate of Levocarnitine which could result in a higher serum level.]
[M01AE04, fenoprofen, The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Cefotetan.]
[N02AB03, fentanyl, Cefotetan may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Cefotetan may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[B01AD05, plasmin, The therapeutic efficacy of Fibrinolysin can be decreased when used in combination with Cefotetan.]
[L01BB06, clofarabine, Cefotetan may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[N07AX03, cevimeline, Cefotetan may decrease the excretion rate of Cevimeline which could result in a higher serum level.]
[G04BD02, flavoxate, Cefotetan may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Floctafenine.]
[J02AC01, fluconazole, Cefotetan may decrease the excretion rate of Fluconazole which could result in a higher serum level.]
[J02AX01, flucytosine, Cefotetan may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Cefotetan may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[V03AZ01, ethanol, The risk or severity of adverse effects can be increased when Cefotetan is combined with Ethanol.]
[L01BC09, floxuridine, Cefotetan may decrease the excretion rate of Floxuridine which could result in a higher serum level.]
[N05CD01, flurazepam, Cefotetan may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, The risk or severity of nephrotoxicity can be increased when Flurbiprofen is combined with Cefotetan.]
[L02BB01, flutamide, Cefotetan may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Cefotetan may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[S02AA17, fosfomycin, Cefotetan may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cefotetan.]
[L01BC03, tegafur, Cefotetan may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[C03CA01, furosemide, Furosemide may decrease the excretion rate of Cefotetan which could result in a higher serum level.]
[M05BA04, alendronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotetan is combined with Alendronic acid.]
[N05CF04, eszopiclone, Cefotetan may decrease the excretion rate of Eszopiclone which could result in a higher serum level.]
[S01AD09, ganciclovir, Cefotetan may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AB04, gemfibrozil, Cefotetan may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.]
[J01XA03, telavancin, Cefotetan may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[A10BB07, glipizide, Cefotetan may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Cefotetan may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.]
[L01EX02, sorafenib, Cefotetan may decrease the excretion rate of Sorafenib which could result in a higher serum level.]
[M01CB04, aurothioglucose, Cefotetan may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Cefotetan may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Cefotetan is combined with Fluindione.]
[C09AA09, fosinopril, Cefotetan may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[S01EX01, guanethidine, Cefotetan may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Cefotetan may decrease the excretion rate of Goserelin which could result in a higher serum level.]
[N05AD01, haloperidol, Cefotetan may decrease the excretion rate of Haloperidol which could result in a higher serum level.]
[N05AH04, quetiapine, Cefotetan may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Cefotetan may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, Cefotetan may decrease the excretion rate of Allopurinol which could result in a higher serum level.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be decreased when used in combination with Cefotetan.]
[G03DC01, allylestrenol, Cefotetan may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cefotetan.]
[C01CE02, milrinone, Cefotetan may decrease the excretion rate of Milrinone which could result in a higher serum level.]
[M02AA26, nimesulide, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Nimesulide.]
[C09AA04, perindopril, Cefotetan may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02DB02, hydralazine, Cefotetan may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Cefotetan.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Cefotetan may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Cefotetan may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.]
[G04BD06, propiverine, Cefotetan may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Cefotetan may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[M05BA07, risedronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotetan is combined with Risedronic acid.]
[R02AX02, ibuprofen, The risk or severity of nephrotoxicity can be increased when Ibuprofen is combined with Cefotetan.]
[B05XA08, sodium acetate, Cefotetan may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, The therapeutic efficacy of Sodium citrate can be decreased when used in combination with Cefotetan.]
[L01AA06, ifosfamide, Cefotetan may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N06AA02, imipramine, Cefotetan may decrease the excretion rate of Imipramine which could result in a higher serum level.]
[R01AD07, tixocortol, Cefotetan may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, Cefotetan may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Cefotetan.]
[A11HA07, inositol, Cefotetan may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Cefotetan may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Cefotetan may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Articaine.]
[A10BH01, sitagliptin, Cefotetan may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Cefotetan may decrease the excretion rate of Alprazolam which could result in a higher serum level.]
[N05CH02, ramelteon, Cefotetan may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Cefotetan may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[J04AC01, isoniazid, Cefotetan may decrease the excretion rate of Isoniazid which could result in a higher serum level.]
[J05AX05, inosine pranobex, Cefotetan may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Cefotetan may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D10BA01, isotretinoin, Cefotetan may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[B01AE06, bivalirudin, The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefotetan.]
[S01AA24, kanamycin, Cefotetan may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[N01AX03, ketamine, Cefotetan may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Cefotetan may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[M02AA10, ketoprofen, The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Cefotetan.]
[M01AE11, tiaprofenic acid, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Tiaprofenic acid.]
[C07AG01, labetalol, Cefotetan may decrease the excretion rate of Labetalol which could result in a higher serum level.]
[N04BB01, amantadine, Cefotetan may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[A06AX03, lubiprostone, Cefotetan may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[C03CC01, ethacrynic acid, The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Cefotetan.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Lidocaine.]
[S01AA21, amikacin, Cefotetan may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA06, lorazepam, Cefotetan may decrease the excretion rate of Lorazepam which could result in a higher serum level.]
[B05XA11, magnesium chloride, Cefotetan may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Cefotetan may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Cefotetan may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Cefotetan.]
[N06AA21, maprotiline, Cefotetan may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Cefotetan may decrease the excretion rate of Mecamylamine which could result in a higher serum level.]
[M02AA18, meclofenamic acid, The risk or severity of nephrotoxicity can be increased when Meclofenamic acid is combined with Cefotetan.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cefotetan.]
[B01AB05, enoxaparin, The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Cefotetan.]
[B01AB04, dalteparin, The therapeutic efficacy of Dalteparin can be decreased when used in combination with Cefotetan.]
[N06DX01, memantine, Cefotetan may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Cefotetan may decrease the excretion rate of Meperidine which could result in a higher serum level.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Mepivacaine.]
[G04BX16, tiopronin, Cefotetan may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Cefotetan may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Cefotetan may decrease the excretion rate of Metformin which could result in a higher serum level.]
[N07BC02, methadone, Cefotetan may decrease the excretion rate of Methadone which could result in a higher serum level.]
[N06BA03, methamphetamine, Cefotetan may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Cefotetan may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Cefotetan may decrease the excretion rate of Methimazole which could result in a higher serum level.]
[L01BA04, pemetrexed, Cefotetan may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Cefotetan may decrease the excretion rate of Pyridoxine which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of nephrotoxicity can be increased when Methotrexate is combined with Cefotetan.]
[D05BA02, methoxsalen, Cefotetan may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Cefotetan may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, Cefotetan may decrease the excretion rate of Methylene blue which could result in a higher serum level.]
[G03EK01, methyltestosterone, Cefotetan may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, Cefotetan may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Cefotetan may decrease the excretion rate of Metoprolol which could result in a higher serum level.]
[V04CD01, metyrapone, Cefotetan may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N02BB03, aminopyrine, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Aminophenazone.]
[B01AB07, parnaparin, The therapeutic efficacy of Parnaparin can be decreased when used in combination with Cefotetan.]
[N05CD08, midazolam, Cefotetan may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[B01AB10, tinzaparin, The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Cefotetan.]
[J05AH01, zanamivir, Cefotetan may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[L03AC01, aldesleukin, Cefotetan may decrease the excretion rate of Aldesleukin which could result in a higher serum level.]
[N06AA09, amitriptyline, Cefotetan may decrease the excretion rate of Amitriptyline which could result in a higher serum level.]
[A04AA05, palonosetron, Cefotetan may decrease the excretion rate of Palonosetron which could result in a higher serum level.]
[J01DD06, moxalactam, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Latamoxef.]
[L04AB05, certolizumab pegol, Cefotetan may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Cefotetan may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Cefotetan may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[C07AA12, nadolol, Cefotetan may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[J01CA04, amoxicillin, Cefotetan may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[V03AB15, naloxone, Cefotetan may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N06BA01, amphetamine, Cefotetan may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[M02AA12, naproxen, The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Cefotetan.]
[N06AX21, duloxetine, Cefotetan may decrease the excretion rate of Duloxetine which could result in a higher serum level.]
[N04BX01, tolcapone, Cefotetan may decrease the excretion rate of Tolcapone which could result in a higher serum level.]
[S03AA01, neomycin, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Neomycin.]
[B01AC17, tirofiban, Cefotetan may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[J02AA01, amphotericin B, The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefotetan.]
[S01AA19, ampicillin, Cefotetan may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[L03AX16, plerixafor, Cefotetan may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Cefotetan may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Cefotetan may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[J05AB11, valacyclovir, The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Cefotetan.]
[C01CE01, inamrinone, Cefotetan may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C08CA05, nifedipine, Cefotetan may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Niflumic acid.]
[C08CA07, nisoldipine, Cefotetan may decrease the excretion rate of Nisoldipine which could result in a higher serum level.]
[R07AX01, nitric oxide, Cefotetan may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Cefotetan may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, Cefotetan may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Cefotetan may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02DD01, nitroprusside, Cefotetan may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[B01AB08, reviparin, The therapeutic efficacy of Reviparin can be decreased when used in combination with Cefotetan.]
[N02AA02, opium, Cefotetan may decrease the excretion rate of Opium which could result in a higher serum level.]
[B01AD07, reteplase, The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefotetan.]
[B01AD09, ancrod, The therapeutic efficacy of Ancrod can be decreased when used in combination with Cefotetan.]
[G04CA02, tamsulosin, Cefotetan may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[M05BA08, zoledronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotetan is combined with Zoledronic acid.]
[J01CF04, oxacillin, Cefotetan may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Cefotetan may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Oxyphenbutazone.]
[B01AB09, danaparoid, The therapeutic efficacy of Danaparoid can be decreased when used in combination with Cefotetan.]
[J04AB30, capreomycin, Cefotetan may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[A07AA06, paromomycin, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Paromomycin.]
[G04BD11, fesoterodine, Cefotetan may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Cefotetan may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[J01CE09, penicillin G procaine, Cefotetan may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, Cefotetan may decrease the excretion rate of Pentobarbital which could result in a higher serum level.]
[L01XX08, pentostatin, Cefotetan may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Cefotetan may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[G04BX06, phenazopyridine, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Phenazopyridine.]
[N06AF03, phenelzine, Cefotetan may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Cefotetan is combined with Phenindione.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Cefotetan is combined with Phenprocoumon.]
[V03AB36, phentolamine, Cefotetan may decrease the excretion rate of Phentolamine which could result in a higher serum level.]
[M02AA01, phenylbutazone, The risk or severity of nephrotoxicity can be increased when Phenylbutazone is combined with Cefotetan.]
[S01AE05, levofloxacin, Cefotetan may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[B02BA01, vitamin K1, Cefotetan may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Cefotetan.]
[C07AA03, pindolol, Cefotetan may decrease the excretion rate of Pindolol which could result in a higher serum level.]
[J01CA12, piperacillin, Cefotetan may decrease the excretion rate of Piperacillin which could result in a higher serum level.]
[N06BX03, piracetam, Cefotetan may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, The risk or severity of nephrotoxicity can be increased when Piroxicam is combined with Cefotetan.]
[J01DD16, cefditoren, The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Cefotetan.]
[B01AC13, abciximab, The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefotetan.]
[S01XA13, alteplase, The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefotetan.]
[A10BG02, rosiglitazone, Cefotetan may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.]
[S03AA03, polymyxin B, The risk or severity of adverse effects can be increased when Cefotetan is combined with Polymyxin B.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BH03, saxagliptin, Cefotetan may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Cefotetan may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[H02AB07, prednisone, Cefotetan may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Prilocaine.]
[M04AB01, probenecid, The serum concentration of Cefotetan can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, Cefotetan may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Cefotetan is combined with Procaine.]
[C10AB05, fenofibrate, Cefotetan may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R06AD02, promethazine, Cefotetan may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[A03AB05, propantheline, Cefotetan may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[C07AA05, propranolol, Cefotetan may decrease the excretion rate of Propranolol which could result in a higher serum level.]
[N02CC04, rizatriptan, Cefotetan may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Cefotetan may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[N07XX07, dalfampridine, Cefotetan may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Cefotetan may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Cefotetan may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[C01BA01, quinidine, Cefotetan may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A02BA02, ranitidine, Cefotetan may decrease the excretion rate of Ranitidine which could result in a higher serum level.]
[C02AA02, reserpine, Cefotetan may decrease the excretion rate of Reserpine which could result in a higher serum level.]
[J05AP01, ribavirin, Cefotetan may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[N02BA05, salicylamide, The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Cefotetan.]
[S01BC08, salicylic acid, The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Cefotetan.]
[N05CA06, secobarbital, Cefotetan may decrease the excretion rate of Secobarbital which could result in a higher serum level.]
[J01GB08, sisomicin, Cefotetan may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Cefotetan may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Cefotetan may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy.]
[N02BA03, choline salicylate, Cefotetan may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[V09AB03, ioflupane I-123, Cefotetan may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Cefotetan may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Cefotetan may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[M05BA01, etidronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefotetan is combined with Etidronic acid.]
[D10AX03, azelaic acid, Cefotetan may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
